HCWB - HCW Biologics Inc
Previous close
0.461
0 0%
Share volume: 5,507
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.46
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-12 | 2022-11-07 | 2023-03-28 | 2023-05-09 | 2023-08-11 | 2023-11-14 | 2024-05-15 | 2024-05-15 | |
| Assets | |||||||||
| Total Assets | 47.408 M | 51.353 M | 46.809 M | 43.535 M | 39.483 M | 35.616 M | 28.514 M | 30.428 M | |
| Current Assets | 34.628 M | 28.708 M | 34.071 M | 29.940 M | 19.799 M | 13.848 M | 6.404 M | 6.209 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.868 M | 2.128 M | 1.591 M | 1.450 M | 1.684 M | 1.917 M | 1.273 M | 1.221 M | |
| Short Term Investments | 1.868 M | 2.128 M | 1.591 M | 1.450 M | 1.684 M | 1.917 M | 1.273 M | 1.221 M | |
| Total Receivables | 346.934 K | 355.555 K | 417.695 K | 252.728 K | 707.211 K | 710.078 K | 1.536 M | 903.884 K | |
| Current Cash | 32.414 M | 26.224 M | 32.062 M | 28.238 M | 17.408 M | 11.221 M | 3.595 M | 4.084 M | |
| Total Non-current Assets | 12.780 M | 22.645 M | 12.738 M | 13.594 M | 19.684 M | 21.768 M | 22.109 M | 24.219 M | |
| Property Plant Equipment | 913.734 K | 10.958 M | 10.805 M | 11.741 M | 12.623 M | 14.781 M | 20.453 M | 22.591 M | |
| Other Assets | 563.512 K | 419.027 K | 333.875 K | 253.144 K | 5.461 M | 5.388 M | 56.538 K | 28.476 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 47.408 M | 51.353 M | 46.809 M | 43.535 M | 39.483 M | 35.616 M | 28.514 M | 30.428 M | |
| Total liabilities | 1.243 M | 8.798 M | 9.381 M | 10.916 M | 10.898 M | 11.749 M | 15.052 M | 21.687 M | |
| Total current liabilities | 1.145 M | 2.293 M | 2.956 M | 4.522 M | 4.538 M | 5.417 M | 8.748 M | 13.413 M | |
| Accounts Payable | 296.207 K | 1.410 M | 1.226 M | 1.165 M | 2.116 M | 3.154 M | 6.167 M | 10.493 M | |
| Other liabilities | 98.447 K | 56.676 K | 14.275 K | 7.476 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 6.448 M | 6.410 M | 6.386 M | 6.360 M | 6.333 M | 6.304 M | 8.274 M | |
| Other liabilities | 98.447 K | 56.676 K | 14.275 K | 7.476 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 46.165 M | 42.555 M | 37.429 M | 32.619 M | 28.586 M | 23.867 M | 13.462 M | 8.741 M | |
| Common stock | 35.814 M | 35.835 M | 35.861 M | 35.884 M | 35.911 M | 35.927 M | 35.996 M | 37.224 M | |
| Retained earnings | -36.205 M | -40.119 M | -45.538 M | -50.609 M | -54.913 M | -59.852 M | -70.532 M | -78.000 M |